Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease
Identifieur interne : 004E93 ( Main/Curation ); précédent : 004E92; suivant : 004E94Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease
Auteurs : Nadir Syed [États-Unis] ; John Murphy [États-Unis] ; Thomas Zimmerman Jr. [États-Unis] ; Margery H. Mark [États-Unis] ; Jacob I. Sage [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1998-03.
Descripteurs français
- Pascal (Inist)
- Wicri :
English descriptors
- KwdEn :
- Administration, Oral, Adult, Aged, Aged, 80 and over, Antiparkinson Agents (administration & dosage), Antiparkinson agent, Chemotherapy, Dyskinesia, Dyskinesia, Drug-Induced (drug therapy), Enteral administration, Female, Fluctuations, Humans, Indication, Infusion, Infusion Pumps, Infusions, Parenteral (instrumentation), Levodopa, Levodopa (administration & dosage), Levodopa (adverse effects), Long term, Male, Middle Aged, Motor Skills (drug effects), Neurologic Examination (drug effects), Parkinson Disease (drug therapy), Parkinson disease, Parkinson's disease, Pump, Route of administration, Treatment, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Levodopa.
- chemical , adverse effects : Levodopa.
- drug effects : Motor Skills, Neurologic Examination.
- drug therapy : Dyskinesia, Drug-Induced, Parkinson Disease.
- instrumentation : Infusions, Parenteral.
- Administration, Oral, Adult, Aged, Aged, 80 and over, Female, Humans, Infusion Pumps, Male, Middle Aged, Treatment Outcome.
Abstract
We report our long‐term experience using enteral levodopa infusions in 22 patients with Parkinson's disease and severe motor fluctuations. Amelioration of intractable dyskinesias was the most important factor that determined whether patients chose to continue using the infusion pump system. Mechanical and physical problems associated with enteral access were the most common reasons for which patients discontinued pump use. Nearly all patients continued to have dramatically increased on time for the duration of follow up, suggesting that technically less‐cumbersome systems that provide continuous dopaminergic stimulation are worthwhile and should be developed.
Url:
DOI: 10.1002/mds.870130222
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003684
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :003684
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003628
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004452
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :004452
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :004326
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :004F21
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :004F21
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :004F21
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :007E05
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003043
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :003781
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002F15
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :008039
Links to Exploration step
ISTEX:54E3E3ED73F72BBA40CAD37A2EEF4D14317CA23BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</title>
<author><name sortKey="Syed, Nadir" sort="Syed, Nadir" uniqKey="Syed N" first="Nadir" last="Syed">Nadir Syed</name>
</author>
<author><name sortKey="Murphy, John" sort="Murphy, John" uniqKey="Murphy J" first="John" last="Murphy">John Murphy</name>
</author>
<author><name sortKey="Zimmerman Jr, Thomas" sort="Zimmerman Jr, Thomas" uniqKey="Zimmerman Jr T" first="Thomas" last="Zimmerman Jr.">Thomas Zimmerman Jr.</name>
</author>
<author><name sortKey="Mark, Margery H" sort="Mark, Margery H" uniqKey="Mark M" first="Margery H." last="Mark">Margery H. Mark</name>
</author>
<author><name sortKey="Sage, Jacob I" sort="Sage, Jacob I" uniqKey="Sage J" first="Jacob I." last="Sage">Jacob I. Sage</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:54E3E3ED73F72BBA40CAD37A2EEF4D14317CA23B</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/mds.870130222</idno>
<idno type="url">https://api.istex.fr/document/54E3E3ED73F72BBA40CAD37A2EEF4D14317CA23B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003684</idno>
<idno type="wicri:Area/Istex/Curation">003684</idno>
<idno type="wicri:Area/Istex/Checkpoint">003628</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Syed N:ten:years:experience</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9539350</idno>
<idno type="wicri:Area/PubMed/Corpus">004452</idno>
<idno type="wicri:Area/PubMed/Curation">004452</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004326</idno>
<idno type="wicri:Area/Ncbi/Merge">004F21</idno>
<idno type="wicri:Area/Ncbi/Curation">004F21</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004F21</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Syed N:ten:years:experience</idno>
<idno type="wicri:Area/Main/Merge">007E05</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:98-0177456</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003043</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003781</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002F15</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Syed N:ten:years:experience</idno>
<idno type="wicri:Area/Main/Merge">008039</idno>
<idno type="wicri:Area/Main/Curation">004E93</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</title>
<author><name sortKey="Syed, Nadir" sort="Syed, Nadir" uniqKey="Syed N" first="Nadir" last="Syed">Nadir Syed</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Murphy, John" sort="Murphy, John" uniqKey="Murphy J" first="John" last="Murphy">John Murphy</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Associated Neurologists, Danbury, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zimmerman Jr, Thomas" sort="Zimmerman Jr, Thomas" uniqKey="Zimmerman Jr T" first="Thomas" last="Zimmerman Jr.">Thomas Zimmerman Jr.</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mark, Margery H" sort="Mark, Margery H" uniqKey="Mark M" first="Margery H." last="Mark">Margery H. Mark</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sage, Jacob I" sort="Sage, Jacob I" uniqKey="Sage J" first="Jacob I." last="Sage">Jacob I. Sage</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1998-03">1998-03</date>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="336">336</biblScope>
<biblScope unit="page" to="338">338</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">54E3E3ED73F72BBA40CAD37A2EEF4D14317CA23B</idno>
<idno type="DOI">10.1002/mds.870130222</idno>
<idno type="ArticleID">MDS870130222</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Dyskinesia</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Enteral administration</term>
<term>Female</term>
<term>Fluctuations</term>
<term>Humans</term>
<term>Indication</term>
<term>Infusion</term>
<term>Infusion Pumps</term>
<term>Infusions, Parenteral (instrumentation)</term>
<term>Levodopa</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Long term</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motor Skills (drug effects)</term>
<term>Neurologic Examination (drug effects)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Pump</term>
<term>Route of administration</term>
<term>Treatment</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Motor Skills</term>
<term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Infusions, Parenteral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Infusion Pumps</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Adulte</term>
<term>Antiparkinsonien</term>
<term>Chimiothérapie</term>
<term>Dyskinésie</term>
<term>Fluctuation motrice</term>
<term>Indication</term>
<term>Long terme</term>
<term>Lévodopa</term>
<term>Parkinson maladie</term>
<term>Pompe</term>
<term>Traitement</term>
<term>Voie administration</term>
<term>Voie entérale</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
<term>Pompe</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report our long‐term experience using enteral levodopa infusions in 22 patients with Parkinson's disease and severe motor fluctuations. Amelioration of intractable dyskinesias was the most important factor that determined whether patients chose to continue using the infusion pump system. Mechanical and physical problems associated with enteral access were the most common reasons for which patients discontinued pump use. Nearly all patients continued to have dramatically increased on time for the duration of follow up, suggesting that technically less‐cumbersome systems that provide continuous dopaminergic stimulation are worthwhile and should be developed.</div>
</front>
</TEI>
<double idat="0885-3185:1998:Syed N:ten:years:experience"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</title>
<author><name sortKey="Syed, N" sort="Syed, N" uniqKey="Syed N" first="N." last="Syed">N. Syed</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Murphy, J" sort="Murphy, J" uniqKey="Murphy J" first="J." last="Murphy">J. Murphy</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Associated Neurologists</s1>
<s2>Danbury, Connecticut</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zimmerman, T Jr" sort="Zimmerman, T Jr" uniqKey="Zimmerman T" first="T. Jr" last="Zimmerman">T. Jr Zimmerman</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mark, M H" sort="Mark, M H" uniqKey="Mark M" first="M. H." last="Mark">M. H. Mark</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sage, J I" sort="Sage, J I" uniqKey="Sage J" first="J. I." last="Sage">J. I. Sage</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0177456</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0177456 INIST</idno>
<idno type="RBID">Pascal:98-0177456</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003043</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003781</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002F15</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Syed N:ten:years:experience</idno>
<idno type="wicri:Area/Main/Merge">008039</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</title>
<author><name sortKey="Syed, N" sort="Syed, N" uniqKey="Syed N" first="N." last="Syed">N. Syed</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Murphy, J" sort="Murphy, J" uniqKey="Murphy J" first="J." last="Murphy">J. Murphy</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Associated Neurologists</s1>
<s2>Danbury, Connecticut</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zimmerman, T Jr" sort="Zimmerman, T Jr" uniqKey="Zimmerman T" first="T. Jr" last="Zimmerman">T. Jr Zimmerman</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mark, M H" sort="Mark, M H" uniqKey="Mark M" first="M. H." last="Mark">M. H. Mark</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sage, J I" sort="Sage, J I" uniqKey="Sage J" first="J. I." last="Sage">J. I. Sage</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School</s1>
<s2>New Brunswick, New Jersey</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Dyskinesia</term>
<term>Enteral administration</term>
<term>Indication</term>
<term>Levodopa</term>
<term>Long term</term>
<term>Parkinson disease</term>
<term>Pump</term>
<term>Route of administration</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Lévodopa</term>
<term>Chimiothérapie</term>
<term>Antiparkinsonien</term>
<term>Long terme</term>
<term>Voie entérale</term>
<term>Dyskinésie</term>
<term>Pompe</term>
<term>Traitement</term>
<term>Voie administration</term>
<term>Indication</term>
<term>Adulte</term>
<term>Fluctuation motrice</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Pompe</term>
<term>Adulte</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</title>
<author><name sortKey="Syed, Nadir" sort="Syed, Nadir" uniqKey="Syed N" first="Nadir" last="Syed">Nadir Syed</name>
</author>
<author><name sortKey="Murphy, John" sort="Murphy, John" uniqKey="Murphy J" first="John" last="Murphy">John Murphy</name>
</author>
<author><name sortKey="Zimmerman Jr, Thomas" sort="Zimmerman Jr, Thomas" uniqKey="Zimmerman Jr T" first="Thomas" last="Zimmerman Jr.">Thomas Zimmerman Jr.</name>
</author>
<author><name sortKey="Mark, Margery H" sort="Mark, Margery H" uniqKey="Mark M" first="Margery H." last="Mark">Margery H. Mark</name>
</author>
<author><name sortKey="Sage, Jacob I" sort="Sage, Jacob I" uniqKey="Sage J" first="Jacob I." last="Sage">Jacob I. Sage</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:54E3E3ED73F72BBA40CAD37A2EEF4D14317CA23B</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/mds.870130222</idno>
<idno type="url">https://api.istex.fr/document/54E3E3ED73F72BBA40CAD37A2EEF4D14317CA23B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003684</idno>
<idno type="wicri:Area/Istex/Curation">003684</idno>
<idno type="wicri:Area/Istex/Checkpoint">003628</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Syed N:ten:years:experience</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9539350</idno>
<idno type="wicri:Area/PubMed/Corpus">004452</idno>
<idno type="wicri:Area/PubMed/Curation">004452</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004326</idno>
<idno type="wicri:Area/Ncbi/Merge">004F21</idno>
<idno type="wicri:Area/Ncbi/Curation">004F21</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004F21</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Syed N:ten:years:experience</idno>
<idno type="wicri:Area/Main/Merge">007E05</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease</title>
<author><name sortKey="Syed, Nadir" sort="Syed, Nadir" uniqKey="Syed N" first="Nadir" last="Syed">Nadir Syed</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Murphy, John" sort="Murphy, John" uniqKey="Murphy J" first="John" last="Murphy">John Murphy</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Associated Neurologists, Danbury, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zimmerman Jr, Thomas" sort="Zimmerman Jr, Thomas" uniqKey="Zimmerman Jr T" first="Thomas" last="Zimmerman Jr.">Thomas Zimmerman Jr.</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mark, Margery H" sort="Mark, Margery H" uniqKey="Mark M" first="Margery H." last="Mark">Margery H. Mark</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sage, Jacob I" sort="Sage, Jacob I" uniqKey="Sage J" first="Jacob I." last="Sage">Jacob I. Sage</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1998-03">1998-03</date>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="336">336</biblScope>
<biblScope unit="page" to="338">338</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">54E3E3ED73F72BBA40CAD37A2EEF4D14317CA23B</idno>
<idno type="DOI">10.1002/mds.870130222</idno>
<idno type="ArticleID">MDS870130222</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Dyskinesia</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Female</term>
<term>Fluctuations</term>
<term>Humans</term>
<term>Infusion</term>
<term>Infusion Pumps</term>
<term>Infusions, Parenteral (instrumentation)</term>
<term>Levodopa</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motor Skills (drug effects)</term>
<term>Neurologic Examination (drug effects)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson's disease</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Motor Skills</term>
<term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Infusions, Parenteral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Infusion Pumps</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report our long‐term experience using enteral levodopa infusions in 22 patients with Parkinson's disease and severe motor fluctuations. Amelioration of intractable dyskinesias was the most important factor that determined whether patients chose to continue using the infusion pump system. Mechanical and physical problems associated with enteral access were the most common reasons for which patients discontinued pump use. Nearly all patients continued to have dramatically increased on time for the duration of follow up, suggesting that technically less‐cumbersome systems that provide continuous dopaminergic stimulation are worthwhile and should be developed.</div>
</front>
</TEI>
</ISTEX>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004E93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:54E3E3ED73F72BBA40CAD37A2EEF4D14317CA23B |texte= Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |